BioAge Labs
€14.32
0
+€0.63+4.6% Today
Statistics
Day High
14.6
Day Low
13.31
52W High
20.6
52W Low
3.38
Volume
118
Avg. Volume
624
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MayExpected
Expected EPS
-0.5473645452
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow Y7G.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.
Show more...
CEO
Dr. Kristen Fortney Ph.D.
Employees
62
Country
United States
ISIN
US09077V1008
Listings
0 Comments
Share your thoughts
FAQ
What is BioAge Labs stock price today?▼
The current price of Y7G.STU is €14.32 EUR — it has increased by +4.6% in the past 24 hours. Watch BioAge Labs stock price performance more closely on the chart.
What is BioAge Labs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioAge Labs stocks are traded under the ticker Y7G.STU.
When is the next BioAge Labs earnings date?▼
BioAge Labs is going to release the next earnings report on May 12, 2026.
What were BioAge Labs earnings last quarter?▼
Y7G.STU earnings for the last quarter are -0.62 EUR per share, whereas the estimation was -0.64 EUR resulting in a +2.49% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does BioAge Labs have?▼
As of April 14, 2026, the company has 62 employees.
In which sector is BioAge Labs located?▼
BioAge Labs operates in the Health & Wellness sector.
When did BioAge Labs complete a stock split?▼
BioAge Labs has not had any recent stock splits.
Where is BioAge Labs headquartered?▼
BioAge Labs is headquartered in Emeryville, United States.